< Back to latest news & events

Event

OPT Congress – Cambridge

March 2019

Event date: 26th March 2019

HGF Patent Director Alison Gallafent will be presenting “siRNA science journey as reflected by the patent literature” at the 4th Annual Oligonucleotide & Precision Therapeautics March 26-28 2019 in Cambridge.

To complement the 4th annual Oligonucleotide Discover and Delivery conference there will also be a 2 day program dedicated to Oligonucleotide CMC and Regulatory Strategies plus two in-depth symposiums focusing on Drug Discovery for Rare Diseases and New Frontiers in Gene Editing and Repair.

The OPT congress brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to provide a unique opportunity to discuss advances in next generation oligonucleotide therapies throughout the drug development process.

Patent Director Alison Gallafent will be presenting “siRNA science journey as reflected by the patent literature”.

Starting with patents that initially reflected manufacturing constraints, moving to patents reflecting greater understanding of chemical modifications, and later product specific patents.  Advantages and potential challenges are associated with patent protection at the different stages of this journey.  Close interaction between Research and Attorney can help to address potential challenges.

Latest updates

Celebrating Success - Director Promotions

We are delighted to announce that 9 of our team have been promoted to director effective from today, 1 December 2023. These promotions are effective from today, 1 December 2023 …

Read article

New Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article
Event - 20th January 2021

HGF & Shiga Webinar Recording: When "Please amend to fall into line with the granted claims in the US" might not work in Europe and Japan

“Please amend to fall into line with the granted claims in the US” is a phrase generally received with caution from attorneys practicing in non-US jurisdictions. The principle cause for …

Event details

High Court’s AI Patent Ruling: A Turning Point for the Patentability of AI?

A recent decision by the UK High Court has delivered a highly favourable verdict for AI innovators, which could change the way that the patentability of AI-related inventions is assessed …

Read article

PRESS RELEASE - HGF Appoints new Chair of the Board: Formerly Head of Engineering, Lucy Johnson

HGF announced a new Chair to its Management Board, Lucy Johnson. Lucy was previously head of the firm’s Engineering Group.  Effective immediately Lucy succeeds Jason Lumber who held the position …

Read article

New Practice at the EPO: Divisional Applications and Sequence Listings

Safeguard measure: Excess page fees on ST.25 sequence listings included as part of a divisional application to be waived by the EPO. Following the implementation of WIPO Sequence standard ST.26, …

Read article